Vasculitis & polymyalgia rheumatica

Role of bronchoscopy for respiratory involvement in eosinophilic granulomatosis with polyangiitis

Clin Exp RheumatolPublished Retrospective cohort study

Authors' conclusion

Bronchoscopy plays a crucial role in patients with EGPA by detecting endobronchial lesions, providing definitive pathological evidence, and identifying eosinophilic infiltration or infections.

Study context

Population
Chinese patients with eosinophilic granulomatosis with polyangiitis (EGPA) who underwent bronchoscopy at initial diagnosis, May 2005 to May 202359 males (54.1%)
Participants
109 patients
Outcome
Bronchoscopic findings at diagnosis
Follow-up
At diagnosis
Methodological detailsdescriptive
  • Descriptive

Main finding

As reported in the abstract

Mucosal oedema and inflammatory changes
95 (87.2%)
Tracheobronchial stenosis
12 (11.0%)
Mucosal nodules and masses
10 (9.2%)
Bleeding
1 (0.9%)
Transbronchial biopsy (TBB) (n=93) with pathological support for EGPA
76 (81.7%)
TBB eosinophilic infiltration
72 (77.4%)
TBB vasculitis
23 (24.7%)
TBB granulomas
7 (7.5%)
Transbronchial needle aspiration of mediastinal lymph nodes: eosinophilic infiltration and granulomas
2
Bronchoalveolar lavage (BAL) (n=89) eosinophilia (>1%)
67 (75.3%)
BAL median percentage of eosinophils
9 (1, 33%)

Observational data: associations, not effects.

Further findings

Clinical, laboratory and chest imaging findings

Asthma
104 (95.4%)
Rhinosinusitis
101 (92.7%)
Peripheral neuropathy
70 (64.2%)
Eosinophilia (>1.0×109/L)
87 (79.8%)
ANCA positivity
18 (16.5%)
Ground-glass opacities
61 (56.0%)
Bronchial wall thickening and bronchiectasis
53 (48.5%)
Consolidation
52 (47.7%)

Original publication

Role of bronchoscopy for respiratory involvement in eosinophilic granulomatosis with polyangiitis. Clin Exp Rheumatol. Published 11 October 2025. doi:10.55563/clinexprheumatol/uoqdnb

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.